NCT05053087View on ClinicalTrials.gov

A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

February 27, 2023

Study Completion Date

February 27, 2023

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Ropivacaine Continuous Infusion

0.2% continuous infusion 6mL/hr

DRUG

Ropivacaine Intermittent Bolus

0.2% intermittent bolus infusion 8mL every 2 hours

DRUG

Placebo

Saline filled catheter

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05053087 - A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter